Literature DB >> 18727682

Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography.

Lia C Liefaard1, Bart A Ploeger, Carla F M Molthoff, Hugo W A M de Jong, Jouke Dijkstra, Louise van der Weerd, Adriaan A Lammertsma, Meindert Danhof, Rob A Voskuyl.   

Abstract

PURPOSE: The purpose of the present investigation was to quantify alterations in GABA(A) receptor density in vivo in rats subjected to amygdala kindling.
METHODS: The GABA(A) receptor density was quantified by conducting a [(11)C]flumazenil (FMZ) positron emission tomography (PET) study according to the full saturation method, in which each animal received a single injection of FMZ to fully saturate the GABA(A) receptors. Subsequently, the concentration-time curves of FMZ in blood [using high-pressure liquid chromatography with UV detector (HPLC-UV) or high-performance liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS)] and brain (with PET-scanning) were analyzed by population modeling using a pharmacokinetic model, containing expressions to describe the time course of FMZ in blood and brain.
RESULTS: The GABA(A) receptor density (B(max)) in kindled rats was decreased by 36% compared with controls. This is consistent with a reduction of 28% in electroencephalography (EEG) effect of midazolam in the same animal model, suggesting that a reduced number of GABA(A) receptors underlies the decreased efficacy of midazolam. Furthermore, receptor affinity (K(D)) was not changed, but the total volume of distribution in the brain (V(Br)), is increased to 178% of control after kindling, which might indicate an alteration in the transport of FMZ across the blood-brain barrier.
CONCLUSIONS: Both the GABA(A) receptor density (B(max)), and possibly also the blood-brain barrier transport of FMZ (V(Br)) are altered after kindling. Furthermore, this study indicates the feasibility of conducting PET studies for quantifying moderate changes in GABA(A) receptor density in a rat model of epilepsy in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727682     DOI: 10.1111/j.1528-1167.2008.01763.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.

Authors:  Floris H P van Velden; Syahir M Mansor; Daniëlle M E van Assema; Bart N M van Berckel; Femke E Froklage; Shaonan Wang; Robert C Schuit; Marie-Claude Asselin; Adriaan A Lammertsma; Ronald Boellaard; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

2.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

Authors:  Martine M Mirrione; Dorothy K Konomos; Iordanis Gravanis; Stephen L Dewey; Adriano Aguzzi; Frank L Heppner; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

3.  Different phases of afterdischarge during rapid kindling procedure in mice.

Authors:  Alberto E Musto; Mark S Samii; Justin F Hayes
Journal:  Epilepsy Res       Date:  2009-04-16       Impact factor: 3.045

4.  Workshop on Neurobiology of Epilepsy appraisal: new systemic imaging technologies to study the brain in experimental models of epilepsy.

Authors:  Stefanie Dedeurwaerdere; Sandy R Shultz; Paolo Federico; Jerome Engel
Journal:  Epilepsia       Date:  2014-05-16       Impact factor: 5.864

5.  Neuroimaging in Animal Seizure Models with (18)FDG-PET.

Authors:  Martine M Mirrione; Stella E Tsirka
Journal:  Epilepsy Res Treat       Date:  2011-07-07

6.  [11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein.

Authors:  Femke E Froklage; Stina Syvänen; N Harry Hendrikse; Marc C Huisman; Carla Fm Molthoff; Yoshihiko Tagawa; Jaap C Reijneveld; Jan J Heimans; Adriaan A Lammertsma; Jonas Eriksson; Elizabeth Cm de Lange; Rob A Voskuyl
Journal:  EJNMMI Res       Date:  2012-03-28       Impact factor: 3.138

7.  Impact of New Scatter Correction Strategies on High-Resolution Research Tomograph Brain PET Studies.

Authors:  Syahir Mansor; Ronald Boellaard; Marc C Huisman; Bart N M van Berckel; Robert C Schuit; Albert D Windhorst; Adriaan A Lammertsma; Floris H P van Velden
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

8.  Assessment of the Optimal Stimulus Pattern to Achieve Rapid Dorsal Hippocampal Kindling in Rats.

Authors:  Fatemeh Etemadi; Mohammad Sayyah; Hamid Gholami Pourbadie; Vahab Babapour
Journal:  Basic Clin Neurosci       Date:  2015-04

9.  Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography.

Authors:  Julia Müllauer; Claudia Kuntner; Martin Bauer; Jens P Bankstahl; Markus Müller; Rob A Voskuyl; Oliver Langer; Stina Syvänen
Journal:  EJNMMI Res       Date:  2012-10-16       Impact factor: 3.138

10.  In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Authors:  Lucy Vivash; Marie-Claude Gregoire; Viviane Bouilleret; Alexis Berard; Catriona Wimberley; David Binns; Peter Roselt; Andrew Katsifis; Damian E Myers; Rodney J Hicks; Terence J O'Brien; Stefanie Dedeurwaerdere
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.